Headline
The latest stories from AHA Today.
The Centers for Disease Control and Prevention issued preliminary guidance for the development of forthcoming contact tracing apps that can help slow the spread of COVID-19.
The Food and Drug Administration said it is adopting more stringent standards for COVID-19 antibody tests.
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
The AHA sent the Health Resources and Services Administration a letter requesting clarifications for several elements of the COVID-19 Uninsured Program.
The Department of Health and Human Services will begin distributing an additional $22 billion in funds from the Public Health and Social Services Emergency Fund.
The U.S. Small Business Administration issued additional guidance clarifying certain provisions implementing the Paycheck Protection Program, including whether public hospitals are eligible for a PPP loan.
The praise and support for our health care heroes is a wonderful thing and we must keep it up.
The AHA and American Nurses Association urged Congress to “act quickly to get needed resources into the health care system,” so that hospitals, nurses and physicians responding to COVID-19 are able to continue to provide treatments, front-line health care personnel are able to provide care and…
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.
The Food and Drug Administration issued Gilead Sciences an emergency use authorization for the investigational antiviral drug remdesivir to treat suspected or laboratory-confirmed COVID-19 in adults and children hospitalized with severe disease.